Role of Oral versus Long-Acting, Second-Generation Medications for Enhancing Adherence and Preventing Rehospitalization in Patients with Schizophrenia

As psychopathology and social functioning can worsen with repeated psychotic episodes, relapse prevention is critical in schizophrenia and because non-adherence decreases response to pharmacotherapy, the use of long-acting, injectable (LAI) antipsychotics is considered an important treatment option....

Full description

Saved in:
Bibliographic Details
Published inThe Arab journal of psychiatry Vol. 32; no. 2; pp. 154 - 161
Main Authors Elsayed , Mona, Sayed , Haydy Hassan
Format Journal Article
LanguageArabic
English
Published Amman - Jordan Arab Federation of Psychiatry 11.01.2021
The Arab Federation of Psychiatrists
Subjects
EGYPT
PATIENTS
PSYCHIATRY
PSYCHOSES
PSYCHOTHERAPY
SCHIZOPHRENIA
إنفصام الشخصية
الذهان
الطب النفسي
العلاج النفسي
المرضى
مصر
Online AccessGet full text

Cover

More Information
Summary:As psychopathology and social functioning can worsen with repeated psychotic episodes, relapse prevention is critical in schizophrenia and because non-adherence decreases response to pharmacotherapy, the use of long-acting, injectable (LAI) antipsychotics is considered an important treatment option. Aims : the current study aims to assess the experience of adherence and rehospitalization in patients with schizophrenia who receive second-generation, oral or long-acting injectable antipsychotics following hospital discharge. Method : a prospective comparative study was carried out from April 2018 to march 2019 in an outpatient psychiatry clinic in Ismailia, Egypt. in total, 70 patients with a diagnosis of schizophrenia were recruited ; ages ranged from 18 to 40 years; and all were allocated to one of two groups. group a consisted of 35 patients maintained on oral, second-generation antipsychotic (SGA). group b consisted of 35 patients maintained on long-acting injection second generation antipsychotic. patients were followed up for one year to assess adherence, discontinuation and rehospitalization. results : patients on long-acting, second generation antipsychotic injection (LAAI) were more adherent and required fewer rehospitalizations than those on oral, second-generation antipsychotics (OAP). conclusion : long-acting antipsychotic injections may have a role in enhancing medication adherence for patients with a diagnosis of schizophrenia and may also decrease the need for hospitalization.
ISSN:1016-8923
DOI:10.12816/0059216